港股异动 | 波司登(3998.HK)涨5.56% 此前纳入MSCI指数获机构看好
格隆汇9月4日丨波司登(3998.HK)今日股价重启升势,现升5.56%,盘中再次刷新约9年来新高。报2.85港元,暂成交3586万港元,最新总市值305亿港元。8月底,MSCI第二次扩容调整正式生效。MSCI中国指数纳入10只股份,波司登(03998.HK)是入选的两只港股之一。据悉,8月8日波司登还获纳入MSCI国际标准中国全股票指数。分析人士指出,波司登被纳入MSCI中国指数10只股份之一,反映了国际权威机构基于公司过去成绩及未来发展投下了信任票。东吴证券称,认为公司高增长、高分红的属性在外资持续流入的背景下将备受青睐,维持“买入”评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.